dc.contributor.author | CANNEY, MARK | en |
dc.contributor.author | KENNY, ROSE | en |
dc.contributor.author | LITTLE, MARK | en |
dc.date.accessioned | 2017-01-12T12:47:35Z | |
dc.date.available | 2017-01-12T12:47:35Z | |
dc.date.issued | 2016 | en |
dc.date.submitted | 2016 | en |
dc.identifier.citation | Canney M, O'Connell MD, Murphy CM, O'Leary N, Little MA, O'Seaghdha CM, Kenny RA, Single Agent Antihypertensive Therapy and Orthostatic Blood Pressure Behaviour in Older Adults Using Beat-to-Beat Measurements: The Irish Longitudinal Study on Ageing., PloS one, 11, 1, 2016, e0146156 | en |
dc.identifier.issn | 1932-6203 | en |
dc.identifier.other | Y | en |
dc.description | PUBLISHED | en |
dc.description.abstract | Background
Impaired blood pressure (BP) stabilisation after standing, defined using beat-to-beat mea-
surements, has been shown to predict important health outcomes. We aimed to define the
relationship between individual classes of antihypertensive agent and BP stabilisation
among hypertensive older adults.
Methods
Cross-sectional analysis from The Irish Longitudinal Study on Ageing, a cohort study of
Irish adults aged 50 years and over. Beat-to-beat BP was recorded in participants undergo-
ing an active stand test. We defined grade 1 hypertension according to European Society of
Cardiology criteria (systolic BP [SBP] 140-159mmHg
±
diastolic BP [DBP] 90-99mmHg).
Outcomes were: (i) initial orthostatic hypotension (IOH) (SBP drop
40mmHg
±
DBP drop
20mmHg within 15 seconds [s] of standing accompanied by symptoms); (ii) sustained OH
(SBP drop
20mmHg
±
DBP drop
10mmHg from 60 to 110s inclusive); (iii) impaired BP
stabilisation (SBP drop
20mmHg
±
DBP drop
10mmHg at any 10s interval during the
test). Outcomes were assessed using multivariable-adjusted logistic regression.
Results
A total of 536 hypertensive participants were receiving monotherapy with a renin-angioten-
sin-aldosterone-system inhibitor (n = 317, 59.1%), beta-blocker (n = 89, 16.6%), calcium
channel blocker (n = 89, 16.6%) or diuretic (n = 41, 7.6%). A further 783 untreated partici-
pants met criteria for grade 1 hypertension. Beta-blockers were associated with increased
odds of initial OH (OR 2.05, 95% CI 1.31
–
3.21) and sustained OH (OR 3.36, 95% CI 1.87
–
6.03) versus untreated grade 1 hypertension. | en |
dc.description.sponsorship | MC was supported by a Health Research
Board research training fellowship grant (HPF-2014-
540). Funding for TILDA was gratefully received from
the Atlantic Philanthropies (
www.
atlanticphilanthropies.org
), the Irish Government, and
the Health Research Board (
www.hrb.ie
). TILDA was
funded by the Department of Health and Atlantic
Philanthropies, along with support from Irish Life in
the form of a charitable gift. The funders had no role
in study design, data collection and analysis, decision
to publish, or preparation of the manuscript. | en |
dc.format.extent | e0146156 | en |
dc.language.iso | en | en |
dc.relation.ispartofseries | PloS one | en |
dc.relation.ispartofseries | 11 | en |
dc.relation.ispartofseries | 1 | en |
dc.rights | Y | en |
dc.subject | blood pressure (BP) stabilisation | en |
dc.subject.lcsh | blood pressure (BP) stabilisation | en |
dc.title | Single Agent Antihypertensive Therapy and Orthostatic Blood Pressure Behaviour in Older Adults Using Beat-to-Beat Measurements: The Irish Longitudinal Study on Ageing. | en |
dc.type | Journal Article | en |
dc.type.supercollection | scholarly_publications | en |
dc.type.supercollection | refereed_publications | en |
dc.identifier.peoplefinderurl | http://people.tcd.ie/canneyma | en |
dc.identifier.peoplefinderurl | http://people.tcd.ie/rkenny | en |
dc.identifier.peoplefinderurl | http://people.tcd.ie/mlittle | en |
dc.identifier.rssinternalid | 111232 | en |
dc.identifier.doi | http://dx.doi.org/10.1371/journal.pone.0146156 | en |
dc.rights.ecaccessrights | openAccess | |
dc.subject.TCDTheme | Ageing | en |
dc.subject.TCDTag | ANTIHYPERTENSIVE AGENTS | en |
dc.subject.TCDTag | OLDER ADULTS | en |
dc.subject.TCDTag | ORTHOSTATIC HYPOTENSION | en |
dc.identifier.orcid_id | 0000-0002-4308-3083 | en |
dc.contributor.sponsor | Health Research Board (HRB) | en |
dc.contributor.sponsorGrantNumber | 13087 (award number) | en |
dc.identifier.uri | http://hdl.handle.net/2262/78701 | |